Global Single B Cell Antibody Service Market Growth (Status and Outlook) 2025-2031

The global Single B Cell Antibody Service market size is predicted to grow from US$ 447 million in 2025 to US$ 595 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.

Single B cell antibody service is a specialized scientific offering that focuses on isolating and exploiting individual B cells from the immune system to generate monoclonal antibodies. It involves advanced techniques to identify and capture antigen-specific B cells directly from various biological samples, such as blood, lymph nodes, or spleen tissues. These captured B cells are then cultured, their antibody-encoding genes are cloned and expressed in appropriate expression systems, enabling the production of highly specific and homogeneous monoclonal antibodies. This service is crucial for a wide range of applications in biomedical research, diagnostics, and therapeutics.

United States market for Single B Cell Antibody Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Single B Cell Antibody Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Single B Cell Antibody Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Single B Cell Antibody Service players cover GenScript, Sino Biological, Inc, ProteoGenix, Biointron, Creative Biolabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Single B Cell Antibody Service Industry Forecast” looks at past sales and reviews total world Single B Cell Antibody Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Single B Cell Antibody Service sales for 2025 through 2031. With Single B Cell Antibody Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single B Cell Antibody Service industry.

This Insight Report provides a comprehensive analysis of the global Single B Cell Antibody Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Single B Cell Antibody Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Single B Cell Antibody Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single B Cell Antibody Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single B Cell Antibody Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Single B Cell Antibody Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Hybridoma Technology
Phage Display Technology
Others

Segmentation by Application:
Biomedical Research
Diagnostics
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GenScript
Sino Biological, Inc
ProteoGenix
Biointron
Creative Biolabs
ACROBiosystems
Sydlabs
Cusabio
Medicilon
Creative Diagnostics
ProBio
Genovac
Active Motif

Please note: The report will take approximately 2 business days to prepare and deliver.